FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164949714> ?p ?o ?g. }

• W2164949714 endingPage "180" @default.
• W2164949714 startingPage "172" @default.
• W2164949714 abstract "Influenza-associated morbidity and mortality has not decreased in the last decade, despite increased receipt of vaccine. To improve the immunogenicity of influenza vaccine, a high-dose (HD) trivalent, inactivated influenza vaccine was developed.A multicenter, randomized, double-blind controlled study was conducted to compare HD vaccine (which contains 60 microg of hemagglutinin per strain) with the licensed standard-dose (SD) vaccine (which contains 15 microg of hemagglutinin per strain) in adults > or = 65 years of age.HD vaccine was administered to 2575 subjects, and SD vaccine was administered to 1262 subjects. There was a statistically significant increase in the rates of seroconversion and mean hemagglutination inhibition titers at day 28 after vaccination among those who received HD vaccine, compared with those who received SD vaccine. Mean postvaccination titers for individuals who received HD vaccine were 116 for H1N1, 609 for H3N2, and 69 for B strain; for those who received SD vaccine, mean postvaccination titers were as 67 for H1N1, 333 for H3N2, and 52 for B strain. The HD vaccine met superiority criteria for both A strains, and the responses for B strain met non-inferiority criteria. Seroprotection rates were also higher for those who received HD vaccine than for those who received SD vaccine vaccine, for all strains. Local reactions were more frequent in individuals who received HD vaccine, but the reactions were mild to moderate.There was a statistically significant increase in the level of antibody response induced by HD influenza vaccine, compared with that induced by SD vaccine, without an attendant increase in the rate or severity of clinically relevant adverse reactions. These results suggest that the high-dose vaccine may provide improved protective benefits for older adults.ClinicalTrials.gov identifier: NCT00391053 ." @default.
• W2164949714 created "2016-06-24" @default.
• W2164949714 creator A5009730605 @default.
• W2164949714 creator A5028253446 @default.
• W2164949714 creator A5042291025 @default.
• W2164949714 creator A5045925315 @default.
• W2164949714 creator A5089284552 @default.
• W2164949714 date "2009-07-15" @default.
• W2164949714 modified "2023-10-10" @default.
• W2164949714 title "Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older" @default.
• W2164949714 cites W1808739935 @default.
• W2164949714 cites W1964541451 @default.
• W2164949714 cites W2004642936 @default.
• W2164949714 cites W2035630057 @default.
• W2164949714 cites W2058144955 @default.
• W2164949714 cites W2060873578 @default.
• W2164949714 cites W2063554346 @default.
• W2164949714 cites W2073199888 @default.
• W2164949714 cites W2095044543 @default.
• W2164949714 cites W2095069717 @default.
• W2164949714 cites W2097222403 @default.
• W2164949714 cites W2100802425 @default.
• W2164949714 cites W2105008429 @default.
• W2164949714 cites W2105974132 @default.
• W2164949714 cites W2107587363 @default.
• W2164949714 cites W2116090359 @default.
• W2164949714 cites W2118490555 @default.
• W2164949714 cites W2129539423 @default.
• W2164949714 cites W2139841187 @default.
• W2164949714 cites W2152368843 @default.
• W2164949714 cites W2154888664 @default.
• W2164949714 cites W2258196722 @default.
• W2164949714 doi "https://doi.org/10.1086/599790" @default.
• W2164949714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19508159" @default.
• W2164949714 hasPublicationYear "2009" @default.
• W2164949714 type Work @default.
• W2164949714 sameAs 2164949714 @default.
• W2164949714 citedByCount "323" @default.
• W2164949714 countsByYear W21649497142012 @default.
• W2164949714 countsByYear W21649497142013 @default.
• W2164949714 countsByYear W21649497142014 @default.
• W2164949714 countsByYear W21649497142015 @default.
• W2164949714 countsByYear W21649497142016 @default.
• W2164949714 countsByYear W21649497142017 @default.
• W2164949714 countsByYear W21649497142018 @default.
• W2164949714 countsByYear W21649497142019 @default.
• W2164949714 countsByYear W21649497142020 @default.
• W2164949714 countsByYear W21649497142021 @default.
• W2164949714 countsByYear W21649497142022 @default.
• W2164949714 countsByYear W21649497142023 @default.
• W2164949714 crossrefType "journal-article" @default.
• W2164949714 hasAuthorship W2164949714A5009730605 @default.
• W2164949714 hasAuthorship W2164949714A5028253446 @default.
• W2164949714 hasAuthorship W2164949714A5042291025 @default.
• W2164949714 hasAuthorship W2164949714A5045925315 @default.
• W2164949714 hasAuthorship W2164949714A5089284552 @default.
• W2164949714 hasBestOaLocation W21649497141 @default.
• W2164949714 hasConcept C133239900 @default.
• W2164949714 hasConcept C159047783 @default.
• W2164949714 hasConcept C159654299 @default.
• W2164949714 hasConcept C182072434 @default.
• W2164949714 hasConcept C203014093 @default.
• W2164949714 hasConcept C22070199 @default.
• W2164949714 hasConcept C2522874641 @default.
• W2164949714 hasConcept C2776872762 @default.
• W2164949714 hasConcept C2777451964 @default.
• W2164949714 hasConcept C2778692840 @default.
• W2164949714 hasConcept C2780689484 @default.
• W2164949714 hasConcept C2780868878 @default.
• W2164949714 hasConcept C2909469553 @default.
• W2164949714 hasConcept C32611913 @default.
• W2164949714 hasConcept C71924100 @default.
• W2164949714 hasConceptScore W2164949714C133239900 @default.
• W2164949714 hasConceptScore W2164949714C159047783 @default.
• W2164949714 hasConceptScore W2164949714C159654299 @default.
• W2164949714 hasConceptScore W2164949714C182072434 @default.
• W2164949714 hasConceptScore W2164949714C203014093 @default.
• W2164949714 hasConceptScore W2164949714C22070199 @default.
• W2164949714 hasConceptScore W2164949714C2522874641 @default.
• W2164949714 hasConceptScore W2164949714C2776872762 @default.
• W2164949714 hasConceptScore W2164949714C2777451964 @default.
• W2164949714 hasConceptScore W2164949714C2778692840 @default.
• W2164949714 hasConceptScore W2164949714C2780689484 @default.
• W2164949714 hasConceptScore W2164949714C2780868878 @default.
• W2164949714 hasConceptScore W2164949714C2909469553 @default.
• W2164949714 hasConceptScore W2164949714C32611913 @default.
• W2164949714 hasConceptScore W2164949714C71924100 @default.
• W2164949714 hasIssue "2" @default.
• W2164949714 hasLocation W21649497141 @default.
• W2164949714 hasLocation W21649497142 @default.
• W2164949714 hasOpenAccess W2164949714 @default.
• W2164949714 hasPrimaryLocation W21649497141 @default.
• W2164949714 hasRelatedWork W1982424639 @default.
• W2164949714 hasRelatedWork W2038899530 @default.
• W2164949714 hasRelatedWork W2044638330 @default.
• W2164949714 hasRelatedWork W2358831769 @default.
• W2164949714 hasRelatedWork W2423096141 @default.
• W2164949714 hasRelatedWork W2799450370 @default.

• next